Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-16

FDA Approved: FAMOTIDINE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approves the original Abbreviated New Drug Application for famotidine from Upsher-Smith Laboratories, LLC, granting a generic version of the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

ORIG AP for FAMOTIDINE (FAMOTIDINE)